| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/19/2006 | CN1251715C Chinese traditional medicine for treating hemorrhoid bloody stool |
| 04/19/2006 | CN1251711C External use anti-inflammatory and myogenic medicine of chinese medicine and its preparing method |
| 04/19/2006 | CN1251709C Health care capsule for middle aged woman |
| 04/19/2006 | CN1251708C Traditional Chinese herb medicine plaster for treating bone injury, and its prepn. method |
| 04/19/2006 | CN1251704C Chinese herbal medicine for treating rhinitis |
| 04/19/2006 | CN1251701C Mammary gland lobular hyperplasia treating plaster and its preparing process |
| 04/19/2006 | CN1251699C Antiviral medicine composition and application thereof |
| 04/19/2006 | CN1251692C Strain of microorganism able to metabolizing daidzein to equol and its prodn. method for equol by using such strain of microorganism |
| 04/19/2006 | CN1251691C Nano-scale pearl powder preparation method |
| 04/19/2006 | CN1251690C Preparing process of active peptide-Lutaisu by making use of spotted deer placenta |
| 04/19/2006 | CN1251689C Veal-blood protein-removed extract infusion and its preparation process |
| 04/19/2006 | CN1251685C Honey-based biological selenium conversion method |
| 04/19/2006 | CN1251674C Medicinal compsn. for treating skin disease and preparation technique |
| 04/19/2006 | CN1251670C Consumable container |
| 04/19/2006 | CN1251669C Acne removing and skin rejuvenating cream |
| 04/19/2006 | CN1251620C Multifunctional fat reducing nutrition drink |
| 04/18/2006 | US7030292 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 04/18/2006 | US7029915 Highly purified hepatic stem cells are trans-differentiated into pancreatic endocrine hormone-producing cells by culturing them in vitro in a medium containing high levels of glucose. These trans differentiated cells express insulin, glucagon and |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029883 Dried extract that is easily incorporated into capsules used for the lowering of cholesterol levels in humans. |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029838 Generating vasculaized tissue; obtain prevascularized graft, mix with sample tissue, propagate tissue, recover vascularized tissue |
| 04/18/2006 | US7029712 Treatment for dry eye syndrome |
| 04/18/2006 | US7029711 Mixture of and method of making a trancutaneous pain relief composition |
| 04/18/2006 | US7029702 Administering various dosage of lactobacullus |
| 04/18/2006 | US7029681 Multiple and multivalent DNA vaccines in ovo |
| 04/18/2006 | US7029671 Method for activating human antigen-presenting cells, activated human antigen-presenting cells, and use thereof |
| 04/18/2006 | US7029670 Medicines for relieving intestinal disorders |
| 04/18/2006 | US7029669 pure culture of Lactobacillus paracasei CNCM I-2116 that adheres to and colonizes intestinal mucosa and preventis infection of intestinal epithelial cells by rotaviruses; may be mixed with foods such as milk, yogurt, cheese, ice cream, fermented cereal based products and infant formula |
| 04/18/2006 | US7029667 encodes a protein or polypeptide which elicits a hyersensitive response in plants; used to impart disease resistance to plants, to enhance plant growth, and/or to control insects on plants |
| 04/18/2006 | US7029666 Uses for non-autologous mesenchymal stem cells |
| 04/18/2006 | US7029664 Chicken leukemia inhibitory factor (LIF) |
| 04/18/2006 | CA2252505C New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 04/18/2006 | CA2089446C Composition for stabilizing blood plasma during pasteurization and pasteurized plasmic solution, for therapeutic purposes |
| 04/13/2006 | WO2006039582A2 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells |
| 04/13/2006 | WO2006039504A2 Method and formulation for stem cells’ stimulation |
| 04/13/2006 | WO2006038869A1 Probiotic lactobacillus strains for improved vaginal health |
| 04/13/2006 | WO2006038690A1 Functional food and drink |
| 04/13/2006 | WO2006038211A2 Disease treatment via developing non-syngeneic graft transplantation |
| 04/13/2006 | WO2006037922A1 Cosmetic and/or dermatological composition for sensitive skins |
| 04/13/2006 | WO2006037224A1 Isolated clk-1 -i- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders |
| 04/13/2006 | WO2006012837A3 Graft structure comprising terminally differentiated tissue cells for the reconstruction of an organ |
| 04/13/2006 | WO2006008401A3 Composition containing a photosynthetic marine and/or fresh-water microorganism culture medium and/or |
| 04/13/2006 | WO2006007710A3 Acute inflammatory condition treatment |
| 04/13/2006 | WO2006005802A8 Method for stimulating mammalian cells and mammalian cell |
| 04/13/2006 | WO2005116192A3 Genetically engineered cells for therapeutic applications |
| 04/13/2006 | WO2005097146A3 Dairy components effective for fat loss |
| 04/13/2006 | WO2005062820A3 Multi plasmid system for the production of influenza virus |
| 04/13/2006 | US20060079440 Treatment of hi-virus infections with oxidised blood proteins |
| 04/13/2006 | US20060078989 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/13/2006 | US20060078971 Isoflavone-beta-D-glucan produced by Agaricus blazei in the submerged liquid culture and method of producing same |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078625 Compositions including krill extracts and conjugated linoleic acid and methods of using same |
| 04/13/2006 | US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 04/13/2006 | US20060078591 Systems and methods for augmenting tissue volume |
| 04/13/2006 | US20060078548 Microorganisms having intestinal cell surface glycosylation modulating action |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078546 Use of lactic acid bacteria to reduce sick time |
| 04/13/2006 | US20060078545 Neural progenitor cell populations |
| 04/13/2006 | US20060078543 Neural progenitor cells derived from embryonic stem cells |
| 04/13/2006 | US20060078541 Method and formula for stem cells' stimulation, targeting release, trafficking and homing |
| 04/13/2006 | US20060078540 Dendritic cell nodes |
| 04/13/2006 | US20060078538 Thermal surgical procedures and compositions |
| 04/13/2006 | DE102004046355A1 New polyethylene glycol compound useful e.g. as solvents for active substances, flavorants or odorants in medical drops, injection solutions, food auxiliary agents, tablets, ointments, sticks or gelatin capsules and softener |
| 04/13/2006 | CA2582963A1 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| 04/13/2006 | CA2582567A1 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
| 04/13/2006 | CA2582429A1 Disease treatment via developing non-syngeneic graft transplantation |
| 04/12/2006 | EP1645635A2 Replication defective recombinant retroviruses expressing a palliative |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1644492A2 Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 04/12/2006 | EP1644487A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 04/12/2006 | EP1644484A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations |
| 04/12/2006 | EP1644478A2 Multi-staged absorbable nonwoven structures for culturing pancreatic cells |
| 04/12/2006 | EP1644086A1 Use of whey permeate for the treatment of metabolic syndrome |
| 04/12/2006 | EP1644011A1 Conditioned matrix compositions for tissue restoration |
| 04/12/2006 | EP1643846A1 Method for treatment of sores and lesions of the skin |
| 04/12/2006 | EP1643837A2 Double dye method to inactivate blood borne pathogens |
| 04/12/2006 | EP1438395A4 Growing xenotransplant material in culture |
| 04/12/2006 | EP1409650B1 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 04/12/2006 | EP1334174B1 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1317272B1 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 04/12/2006 | EP1280541B1 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
| 04/12/2006 | EP1263448B1 Maca and antler for augmenting testosterone levels |
| 04/12/2006 | EP1118659B1 Expression systems for functional nucleic acid expression |
| 04/12/2006 | EP0985046B1 Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines |
| 04/12/2006 | EP0942739B1 Biomaterial derived from vertebrate liver tissue |
| 04/12/2006 | CN1759316A Blood cell separation membrane and blood retention tool including the same |
| 04/12/2006 | CN1757743A Isoflavone-containing composition |
| 04/12/2006 | CN1757412A Prescription of hair-nourishing and hair black preparation, and prepn. method |
| 04/12/2006 | CN1757397A Biological deodorization method for dried oviduct fat of forest frog |
| 04/12/2006 | CN1757396A Ursine fat injection emulsion, and its prepn. method |
| 04/12/2006 | CN1757395A Pure ursine fat, and its prepn. method |
| 04/12/2006 | CN1757286A Calcium tonifying cracker prodn. method |
| 04/12/2006 | CN1250732C 病毒株 Strains |
| 04/12/2006 | CN1250731C Packaging of positive-strand RNA virus replicon particles |
| 04/12/2006 | CN1250715C Method for cloning animals by using nucleus of differentiated diploid donor cell |